These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. No variants in the cardiac actin gene in Finnish patients with dilated or hypertrophic cardiomyopathy. Kärkkäinen S; Peuhkurinen K; Jääskeläinen P; Miettinen R; Kärkkäinen P; Kuusisto J; Laakso M Am Heart J; 2002 Jun; 143(6):E6. PubMed ID: 12075240 [TBL] [Abstract][Full Text] [Related]
46. Sudden Unexpected Death of Infantile Dilated Cardiomyopathy with JPH2 and PKD1 Gene Variants. Miura A; Kondo H; Yamamoto T; Okumura Y; Nishio H Int Heart J; 2020 Sep; 61(5):1079-1083. PubMed ID: 32879264 [TBL] [Abstract][Full Text] [Related]
47. X-linked dilated cardiomyopathy: the important role of genetic tests and imaging in the early diagnosis and treatment. Tsalamandris S; Oikonomou E; Vogiatzi G; Miliou A; Lazaros G; Georgakopoulos C; Gialafos E; Sideris S; Vlachopoulos C; Tousoulis D Future Cardiol; 2020 Nov; 16(6):629-634. PubMed ID: 32508136 [TBL] [Abstract][Full Text] [Related]
48. Bi-allelic missense disease-causing variants in RPL3L associate neonatal dilated cardiomyopathy with muscle-specific ribosome biogenesis. Ganapathi M; Argyriou L; Martínez-Azorín F; Morlot S; Yigit G; Lee TM; Auber B; von Gise A; Petrey DS; Thiele H; Cyganek L; Sabater-Molina M; Ahimaz P; Cabezas-Herrera J; Sorlí-García M; Zibat A; Siegelin MD; Burfeind P; Buchovecky CM; Hasenfuss G; Honig B; Li Y; Iglesias AD; Wollnik B Hum Genet; 2020 Nov; 139(11):1443-1454. PubMed ID: 32514796 [TBL] [Abstract][Full Text] [Related]
49. Implications of Genetic Testing in Dilated Cardiomyopathy. Verdonschot JAJ; Hazebroek MR; Krapels IPC; Henkens MTHM; Raafs A; Wang P; Merken JJ; Claes GRF; Vanhoutte EK; van den Wijngaard A; Heymans SRB; Brunner HG Circ Genom Precis Med; 2020 Oct; 13(5):476-487. PubMed ID: 32880476 [TBL] [Abstract][Full Text] [Related]
50. Massive parallel sequencing questions the pathogenic role of missense variants in dilated cardiomyopathy. Dalin MG; Engström PG; Ivarsson EG; Unneberg P; Light S; Schaufelberger M; Gilljam T; Andersson B; Bergo MO Int J Cardiol; 2017 Feb; 228():742-748. PubMed ID: 27886618 [TBL] [Abstract][Full Text] [Related]
51. Association of uncertain significance genetic variants with myocardial mechanics and morphometrics in patients with nonischemic dilated cardiomyopathy. Mėlinytė-Ankudavičė K; Šukys M; Kasputytė G; Krikštolaitis R; Ereminienė E; Galnaitienė G; Mizarienė V; Šakalytė G; Krilavičius T; Jurkevičius R BMC Cardiovasc Disord; 2024 Apr; 24(1):224. PubMed ID: 38664609 [TBL] [Abstract][Full Text] [Related]
52. Considering complexity in the genetic evaluation of dilated cardiomyopathy. Jordan E; Hershberger RE Heart; 2021 Jan; 107(2):106-112. PubMed ID: 33109712 [TBL] [Abstract][Full Text] [Related]
53. Genotype and Cardiac Outcomes in Pediatric Dilated Cardiomyopathy. Khan RS; Pahl E; Dellefave-Castillo L; Rychlik K; Ing A; Yap KL; Brew C; Johnston JR; McNally EM; Webster G J Am Heart Assoc; 2022 Jan; 11(1):e022854. PubMed ID: 34935411 [TBL] [Abstract][Full Text] [Related]
54. Clinical characterisation of a novel Kean AC; Helm BM; Vatta M; Ayers MD; Parent JJ; Darragh RK Cardiol Young; 2019 Oct; 29(10):1257-1263. PubMed ID: 31477192 [TBL] [Abstract][Full Text] [Related]
58. A novel likely pathogenic variant in the FBXO32 gene associated with dilated cardiomyopathy according to whole‑exome sequencing. Ghasemi S; Mahdavi M; Maleki M; Salahshourifar I; Kalayinia S BMC Med Genomics; 2022 Nov; 15(1):234. PubMed ID: 36344977 [TBL] [Abstract][Full Text] [Related]
59. An intervention strategy to improve genetic testing for dilated cardiomyopathy in a heart failure clinic. Mohananey A; Tseng AS; Julakanti RR; Gonzalez-Bonilla HM; Kruisselbrink T; Prochnow C; Rodman S; Lin G; Redfield MM; Rosenbaum AN; Pereira NL Genet Med; 2023 Mar; 25(3):100341. PubMed ID: 36472615 [TBL] [Abstract][Full Text] [Related]